tiprankstipranks
Trending News
More News >
Healthstream (HSTM)
NASDAQ:HSTM
Advertisement

HealthStream (HSTM) AI Stock Analysis

Compare
120 Followers

Top Page

HSTM

HealthStream

(NASDAQ:HSTM)

Select Model
Select Model
Select Model
Outperform 75 (OpenAI - 4o)
Rating:75Outperform
Price Target:
$32.00
▲(9.81% Upside)
HealthStream's strong financial performance and strategic advancements in AI and core solutions are significant strengths. However, the high P/E ratio and technical indicators suggest caution due to potential overvaluation and short-term pullback risks.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong demand for HealthStream's solutions, enhancing its market position and financial stability.
AI and Innovation
Integration of AI technologies positions HealthStream at the forefront of innovation, potentially driving future growth and competitive advantage.
Financial Strength
Strong financial performance and cash reserves provide HealthStream with flexibility to invest in growth opportunities and withstand market fluctuations.
Negative Factors
Gross Margin Decline
Declining gross margins due to rising costs could pressure profitability, affecting long-term financial health if not managed effectively.
Legacy Product Declines
Decreasing revenue from legacy products may indicate challenges in maintaining older product lines, impacting overall revenue stability.
Operational Challenges
Operational challenges with key products like CredentialStream could hinder efficiency and profitability, affecting long-term growth prospects.

HealthStream (HSTM) vs. SPDR S&P 500 ETF (SPY)

HealthStream Business Overview & Revenue Model

Company DescriptionHealthStream, Inc. provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the range of its clinical development, talent management, training, education, certification, scheduling, competency assessment, performance appraisal, and other needs, as well as implementation and account management services. It also provides applications for learning, performance appraisal, competency management, disclosure management, clinical assessment and development, simulation-based education, quality management, and industry training. In addition, the company offers VerityStream that delivers enterprise-class solutions to transform the healthcare provider experience for ambulatory surgery centers, urgent care facilities, clinics, medical groups, and other healthcare organizations; EchoCredentialing and MSOW platforms that manage medical staff credentialing, enrollment, and privileging processes for hospitals; and EchoOneApp, a provider enrollment platform for medical groups. Further, it provides CredentialMyDoc, a credentialing and enrollment SaaS solution for medical groups and surgery centers; CredentialStream, a SaaS-based provider credentialing, privileging, and enrollment solution; and NurseGrid Mobile for nurse managers. The company offers its solutions in healthcare industry companies that include private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through direct sales teams. HealthStream, Inc. was incorporated in 1990 and is headquartered in Nashville, Tennessee.
How the Company Makes MoneyHealthStream generates revenue primarily through subscription fees for its software solutions and services. The company offers various subscription-based products, which provide healthcare organizations with ongoing access to its platforms and resources. Key revenue streams include fees from its learning management systems, which facilitate employee training and compliance, as well as patient engagement solutions that help enhance the patient experience. Additionally, HealthStream benefits from strategic partnerships with healthcare providers and organizations, which can lead to increased adoption of its solutions and additional revenue opportunities. The company's focus on the healthcare sector allows it to capitalize on the growing demand for effective workforce and patient management tools, contributing significantly to its earnings.

HealthStream Earnings Call Summary

Earnings Call Date:Aug 04, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Oct 27, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted strong financial performance and strategic advancements, particularly in AI and deal closures, but was tempered by operational challenges, particularly in legacy product declines and gross margin pressures.
Q2-2025 Updates
Positive Updates
Record-Breaking Revenue
Achieved record quarterly revenue of $74.4 million, up 4% from the same quarter last year.
Significant Deal Closures
Closed 4 out of 5 large deals, with an average contract value of $2.2 million, including a multimillion-dollar contract for the American Red Cross Resuscitation program.
Strong Performance in Core Solutions
CredentialStream grew by 26%, ShiftWizard by 21%, and the competency suite by 18%.
AI and Innovation
Launched the HealthStream Learning Experience (HLX) with 47,000 users and incorporated AI technologies such as OpenAI's GPT-4.0.
Financial Strength
Net income up 29.3% and adjusted EBITDA up 11.3%. Maintained strong cash position with $90.6 million and no debt.
Negative Updates
Gross Margin Decline
Gross margin was impacted by increased cloud hosting costs and higher royalty costs, falling to 64.6% from 66.8%.
Legacy Product Declines
Declines from legacy products in credentialing and scheduling totaled $1.8 million compared to last year.
Operational Challenges with CredentialStream
Faced technology scaling issues with CredentialStream, leading to increased operating costs and a drag on EBITDA.
Delayed Deal Closures
Expectations for deal closures were delayed, impacting the sales pipeline.
Company Guidance
During the second quarter of 2025, HealthStream reported record quarterly revenue, increasing by 4% compared to the same period last year. Operating income surged by 33.4%, while net income rose by 29.3%. Adjusted EBITDA also saw an 11.3% increase. The company successfully closed four out of five major deals, with an average contract value of $2.2 million, and anticipates completing the fifth deal early in the third quarter. HealthStream's financial guidance for 2025 includes raised expectations for net income, while projections for revenue, adjusted EBITDA, and capital expenditures remain steady. The company's core solutions, CredentialStream, ShiftWizard, and competency suite, showed significant growth, with CredentialStream revenue growing by 26%, ShiftWizard by 21%, and the competency suite by 18%. Despite some challenges with legacy products, HealthStream continues to focus on integrating AI into its operations and product offerings, such as the GenAI and HealthStream Learning Experience (HLX) applications. The company maintains a strong financial position with a cash balance of $90.6 million, no debt, and a disciplined capital allocation strategy.

HealthStream Financial Statement Overview

Summary
HealthStream exhibits strong revenue growth and profitability, supported by a solid balance sheet with low leverage. While cash flow generation is improving, the conversion of earnings to free cash flow could be enhanced. Overall, the company is well-positioned financially, with opportunities to optimize operational efficiency further.
Income Statement
82
Very Positive
HealthStream demonstrates strong revenue growth with a TTM increase of 9.71%, indicating robust demand for its services. The gross profit margin remains healthy at 65.64%, reflecting efficient cost management. However, the EBIT margin has slightly decreased to 5.54%, suggesting increased operational costs. Overall, the company maintains a solid net profit margin of 6.89%, showcasing profitability.
Balance Sheet
78
Positive
The company maintains a low debt-to-equity ratio of 0.045, indicating prudent financial leverage. Return on equity is moderate at 5.70%, showing reasonable efficiency in generating profits from shareholders' equity. The equity ratio stands at 70.07%, reflecting a strong capital structure with significant equity financing.
Cash Flow
75
Positive
Operating cash flow to net income ratio is stable at 0.54, indicating good cash conversion from earnings. Free cash flow has grown by 6.99% TTM, highlighting improved cash generation. However, the free cash flow to net income ratio of 0.73 suggests that a portion of earnings is not translating into free cash flow, which could be a point of concern.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue295.21M291.65M279.06M266.83M256.71M244.83M
Gross Profit193.78M193.71M184.04M175.68M165.68M155.49M
EBITDA65.38M62.53M59.59M53.53M44.87M46.01M
Net Income20.34M20.01M15.21M12.09M5.84M14.09M
Balance Sheet
Total Assets500.15M510.77M499.94M497.74M486.75M500.31M
Cash, Cash Equivalents and Short-Term Investments90.62M97.22M71.13M53.91M51.95M46.49M
Total Debt15.89M20.17M20.25M23.32M26.18M28.48M
Total Liabilities149.58M151.41M159.19M163.68M147.73M166.25M
Stockholders Equity350.57M359.36M340.75M334.06M339.02M334.06M
Cash Flow
Free Cash Flow45.32M29.52M35.96M26.09M17.04M17.07M
Operating Cash Flow62.37M57.66M63.97M51.19M42.38M35.87M
Investing Cash Flow-33.34M-33.97M-56.60M-28.39M-25.72M-110.41M
Financing Cash Flow-23.04M-4.52M-13.04M-23.70M-6.21M-20.49M

HealthStream Technical Analysis

Technical Analysis Sentiment
Positive
Last Price29.14
Price Trends
50DMA
27.44
Positive
100DMA
27.57
Positive
200DMA
29.92
Negative
Market Momentum
MACD
0.48
Positive
RSI
62.14
Neutral
STOCH
43.04
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HSTM, the sentiment is Positive. The current price of 29.14 is above the 20-day moving average (MA) of 28.66, above the 50-day MA of 27.44, and below the 200-day MA of 29.92, indicating a neutral trend. The MACD of 0.48 indicates Positive momentum. The RSI at 62.14 is Neutral, neither overbought nor oversold. The STOCH value of 43.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HSTM.

HealthStream Risk Analysis

HealthStream disclosed 38 risk factors in its most recent earnings report. HealthStream reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

HealthStream Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$859.59M43.595.81%0.42%3.50%13.99%
66
Neutral
1.42B-57.01-8.07%15.31%77.02%
51
Neutral
1.05B-5.57-18.04%-6.71%-71.40%
51
Neutral
1.44B-6.83-14.58%-2.57%79.86%
49
Neutral
197.05M-1.85-28.81%5.55%-0.99%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HSTM
HealthStream
29.14
0.42
1.46%
EVH
Evolent Health
8.95
-19.33
-68.35%
HCAT
Health Catalyst
2.80
-5.34
-65.60%
NUTX
Clinigence Holdings
102.53
80.83
372.49%
DH
Definitive Healthcare Corp
3.98
-0.49
-10.96%
OMDA
Omada Health, Inc.
22.78
0.18
0.80%

HealthStream Corporate Events

Stock BuybackDividendsFinancial Disclosures
HealthStream Reports Record Q2 2025 Revenue Growth
Positive
Aug 4, 2025

On August 4, 2025, HealthStream announced its second quarter 2025 results, reporting a record revenue of $74.4 million, a 4% increase from the previous year. The company also declared a quarterly cash dividend and highlighted a significant improvement in operating income and net income compared to the second quarter of 2024. Additionally, HealthStream’s Board of Directors authorized a share repurchase program, which was completed in July 2025.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 28, 2025